Effect of L-DOPA on blood pressure and sympathetic nerve activity after decarboxylase inhibition in cats
Watanabe, A.M.; Judy, W.V.; Cardon, P.V.
Journal of Pharmacology and Experimental Therapeutics 188(1): 107-113
1974
ISSN/ISBN: 0022-3565 PMID: 4809262 Document Number: 74511
Document emailed within 1 workday
Related Documents
Blair, M.L.; Reid, I.A.; Ganong, W.F. 1977: Effect of L-dopa on plasma renin activity with and without inhibition of extracerebral dopa decarboxylase in dogs Journal of Pharmacology and Experimental Therapeutics 202(1): 209-215Pontiroli, A.E.; Castegnaro, E.; Vettaro, M.P.; Viberti, G.C.; Pozza, G. 1977: Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine Acta Endocrinologica 84(1): 36-44
Eisenlohr, J.J.; Gehlen, W. 1975: Changes of blood pressure, pulse and electrolytes following long-term treatment of Parkinsonism using Ro 8-0576 (L-Dopa and decarboxylase inhibitor) Der Nervenarzt 46(3): 128-135
Aibiki, M.; Koyama, S.; Fujita, T. 1991: Effects of RA642, a new central pressor agent, on renal sympathetic nerve activity and blood pressure during hemorrhagic shock in rabbits Circulatory Shock 34(2): 240-246
Yamori, Y.; De Jong, W.; Yamabe, H.; Lovenberg, W.; Sjoerdsma, A. 1972: Effects of L-dopa and inhibitors of decarboxylase and monoamine oxidase on brain noradrenaline levels and blood pressure in spontaneously hypertensive rats Journal of Pharmacy and Pharmacology 24(9): 690-695
Ohashi, K.; Nishikawa, K.; Hatano, M.; Mori, T.; Asada, A. 2002: Dose-related attenuation of cardiac sympathetic nerve activity and intracardiac conduction with thoracic epidural clonidine in alpha-chloralose-anesthetized cats Osaka City Medical Journal 48(1): 45-58
Undesser, K.P.; Pan, J.Y.; Lynn, M.P.; Bishop, V.S. 1985: Baroreflex control of sympathetic nerve activity after elevations of pressure in conscious rabbits American Journal of Physiology 248(6 Pt 2): H827-H834
Malacrida, A.; Cima, L.; Gasperi, G.; Grigolo, A. 1974: Studies on the activity of the enzyme DOPA decarboxylase in Musca domestica L Italian Journal of Biochemistry 23(1): 12-18
Fedina, L.; Kovách, A.G.; Huszár, V. 1970: Effect of 1-(4-oxyphenyl)-2n-butylamino-ethanone hydrochloride (BON) on blood circulation. 3. Effect on the sympathetic nerve fibres of the heart and kidneys Arzneimittel-Forschung 20(Suppl 11a): 1656
Bergonzi, P.; Chiurulla, C.; Gambi, D.; Mennuni, G.; Pinto, F. 1975: L-dopa plus dopa-decarboxylase inhibitor. Sleep organization in Parkinson's syndrome before and after treatment Acta Neurologica Belgica 75(1): 5-10
Guillard, A. 1972: Treatment of Parkinson syndromes with L-Dopa and the association of L-Dopa and a decarboxylase inhibitor Bruxelles Medical 52(10): 673-680
Gauthier, G.; de Ajuriaguerra, J.; Geissbuhler, F.; Simona, B.; Constantinidis, J.; Yanniotis, G.; Krassoievitch, M.; Eisenring, J.J.; Tissot, R. 1971: Substitutive therapy in Parkinson's syndromes. L-dopa plus peripheral decarboxylase inhibitor or 3-0-methyl dopa? La Presse Medicale 79(3): 91-92
Matussek, N.; Benkert, O.; Schneider, K.; Otten, H.; Pohlmeier, H. 1970: Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions Arzneimittel-Forschung 20(7): 934-935
Scheuer, D.A.; Bishop, V.S. 1996: Effect of vasopressin on baroreflex control of lumbar sympathetic nerve activity and hindquarter resistance American Journal of Physiology 270(6 Pt 2): H1963-H1971
Randall, D.C.; Brown, D.R.; Brown, L.V.; Kilgore, J.M. 1994: Sympathetic nervous activity and arterial blood pressure control in conscious rat during rest and behavioral stress American Journal of Physiology 267(5 Pt 2): R1241-R1249
Koyama, K.; Kushiro, T.; Kajiwara, N. 1988: Effects of low calorie regimen in blood pressure of obese hypertensive subjects: relation to sympathetic activity Nihon Jinzo Gakkai Shi 30(8): 1047-1052
Geissbuhler, F.; Eisenring, J.J.; Friedli, P.; Bartholini, G.; Tissot, R. 1972: Cerebral and peripheral L-dopa uptake in patients with parkinsonian, depressive or manic syndromes administered L-dopa by perfusion combined or not with a decarboxylase inhibitor. Pharmacological effects L'Encephale 61(2): 127-148
Eisenlohr, J.J.; Gehlen, W. 1974: Long-term study on the anti-rigidity effect of L-dopa and a decarboxylase inhibitor (ro 8-0576) Münchener Medizinische Wochenschrift 116(28): 1353-1356
Kirchner, F.; Lamprecht, F.; Philippi, A.; Steinriede, R. 1972: Relation between the activity of the sympathetic renal nerves and plasma renin activity in narcotized cats Zeitschrift für Kreislaufforschung 61(1): 52-59
Recordati, G.; Zorzoli, F.; Zanchetti, A. 2000: Effects of a reversible 'nephrectomy' on renal sympathetic activity and blood pressure in the rat: evidence for an acute angiotensin-mediated hypertension Journal of Hypertension 18(9): 1277-1287